Reply to López-Campos and to Rogliani and Calzetta.
作者信息
Martinez Fernando J, Darken Patrick, Dorinsky Paul
机构信息
Weill Cornell Medicine New York, New York.
AstraZeneca Wilmington, Delaware and.
出版信息
Am J Respir Crit Care Med. 2021 Apr 1;203(7):927-928. doi: 10.1164/rccm.202012-4484LE.
Abstract
摘要
相似文献
1
Reply to López-Campos and to Rogliani and Calzetta.对洛佩斯 - 坎波斯以及罗利亚尼和卡尔泽塔的回复。
Am J Respir Crit Care Med. 2021 Apr 1;203(7):927-928. doi: 10.1164/rccm.202012-4484LE.
2
Pharmacokinetics of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler formulated using co-suspension delivery technology after single and chronic dosing in patients with COPD.布地奈德/格隆溴铵/富马酸福莫特罗定量吸入气雾剂混悬液给药技术在 COPD 患者单剂量和慢性给药后的药代动力学。
Pulm Pharmacol Ther. 2020 Feb;60:101873. doi: 10.1016/j.pupt.2019.101873. Epub 2019 Dec 10.
3
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial.布地奈德/格隆溴铵/富马酸福莫特罗联合混悬液给药技术三联疗法对比慢性阻塞性肺疾病（KRONOS）中的双联疗法：一项双盲、平行分组、多中心、3 期随机对照临床试验。
Lancet Respir Med. 2018 Oct;6(10):747-758. doi: 10.1016/S2213-2600(18)30327-8. Epub 2018 Sep 16.
4
Functional respiratory imaging assessment of budesonide/glycopyrrolate/formoterol fumarate and glycopyrrolate/formoterol fumarate metered dose inhalers in patients with COPD: the value of inhaled corticosteroids.布地奈德/格隆溴铵/富马酸福莫特罗和格隆溴铵/富马酸福莫特罗定量吸入器在 COPD 患者中的功能呼吸成像评估：吸入皮质类固醇的价值。
Respir Res. 2021 Jul 1;22(1):191. doi: 10.1186/s12931-021-01772-2.
5
Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Chinese Patients with COPD: A Subgroup Analysis of KRONOS.布地奈德/格隆溴铵/福莫特罗富马酸酯干粉吸入剂在中国 COPD 患者中的疗效和安全性：KRONOS 的亚组分析。
Adv Ther. 2020 Apr;37(4):1591-1607. doi: 10.1007/s12325-020-01266-5. Epub 2020 Mar 6.
6
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study.ETHOS 研究中布地奈德/格隆溴铵/福莫特罗治疗慢性阻塞性肺疾病降低全因死亡率：一项随机、双盲、多中心、平行分组研究。
Am J Respir Crit Care Med. 2021 Mar 1;203(5):553-564. doi: 10.1164/rccm.202006-2618OC.
7
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.中重度至极重度 COPD 患者两种糖皮质激素剂量三联吸入治疗。
N Engl J Med. 2020 Jul 2;383(1):35-48. doi: 10.1056/NEJMoa1916046. Epub 2020 Jun 24.
8
Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD.采用共悬浮给药技术的布地奈德/格隆溴铵/富马酸福莫特罗气雾剂在日本 COPD 患者中的长期安全性和疗效。
Int J Chron Obstruct Pulmon Dis. 2019 Dec 23;14:2993-3002. doi: 10.2147/COPD.S220861. eCollection 2019.
9
Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study.使用共悬浮递送技术制备的布地奈德/格隆溴铵/富马酸福莫特罗定量吸入气雾剂在日本 COPD 患者中的疗效和安全性：KRONOS 研究的亚组分析。
Int J Chron Obstruct Pulmon Dis. 2019 Dec 23;14:2979-2991. doi: 10.2147/COPD.S220850. eCollection 2019.
10
Ethnic pharmacokinetic comparison of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler (BGF MDI) between Asian and Western healthy subjects.布地奈德/格隆溴铵/富马酸福莫特罗定量吸入气雾剂（BGF MDI）在亚洲和西方健康受试者中的种族药代动力学比较。
Pulm Pharmacol Ther. 2020 Oct;64:101976. doi: 10.1016/j.pupt.2020.101976. Epub 2020 Nov 2.
本文引用的文献
1
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.中重度至极重度 COPD 患者两种糖皮质激素剂量三联吸入治疗。
N Engl J Med. 2020 Jul 2;383(1):35-48. doi: 10.1056/NEJMoa1916046. Epub 2020 Jun 24.
Zotero 插件